Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
61.03 USD | +2.81% | -7.38% | -27.59% |
13/05 | Transcript : Cytokinetics, Incorporated - Special Call | |
09/05 | Oppenheimer Adjusts Cytokinetics Price Target to $106 From $107, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.59% | 6.22B | |
+7.36% | 111B | |
+11.40% | 106B | |
-12.60% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.57% | 16.81B | |
+37.38% | 12.54B | |
-24.08% | 8.09B |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- UBS Trims Cytokinetics' Price Target to $61 From $62, Keeps Buy Rating